Fermenta Biotech — 360° view

Fermenta Biotech, a company in the Pharmaceuticals industry, reported revenue of ₹133 crore and net profit of ₹9.44 crore for the September 2026 quarter.

Fermenta Biotech (NSE: FERMENTA) closed at ₹446.15 on 20 Nov 2026. Its market capitalisation is ₹1,313 crore and it trades at 28.3 times earnings.

Share price
₹446.15 (20 Nov 2026)
Market cap
₹1,313 Cr (20 Nov 2026)
P/E
28.27 (20 Nov 2026)
Revenue
₹133 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
20.6% (FY26)
ROE
17.3% (FY26)
Book value
₹142 (FY26)
Dividend yield
0.84% (last 12 months to 20 Nov 2026)
52-week high / low
₹582.65 / ₹248.85 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: FERMENTA

Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.